Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA‐MM subgroup analysis. Issue 11 (23rd September 2021) - Schjesvold, Fredrik; Bringhen, Sara; G. Richardson, Paul; Perrot, Aurore; Leleu, Xavier; Moreau, Philippe; A. Dimopoulos, Meletios; Hulin, Cyrille; Tekle, Christina; Foster, Meredith C.; Poole, Elizabeth M.; van de Velde, Helgi; et al.